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DOI: 10.1039/c0ce00461hCocrystals have been increasingly recognized as an attractive alternative delivery form for solid drug
products. In this work, Raman spectroscopy, X-ray powder diffraction/X-ray crystallography, and
differential scanning calorimetry have been used to study the phenomenon of cocrystal formation in
stoichiometric mixtures of citric acid with paracetamol. Raman spectroscopy was particularly useful
for the characterization of the products and was used to determine the nature of the interactions in the
cocrystals. It was observed that little change in the vibrational modes associated with the phenyl groups
of the respective reactants took place upon cocrystal formation but changes in intensities of the
vibrational modes associated with the amide and the carboxylic acid groups were observed upon
cocrystal formation. Several new vibrational bands were identified in the cocrystal which were not
manifest in the raw material and could be used as diagnostic features of cocrystal formation. An
understanding of the effects of cocrystal formation on the vibrational modes was obtained by the
complete assignment of the spectra of the starting materials and of the cocrystal component. The results
show that the cocrystals was obtained in a 2 : 1 molar ratio of paracetamol to citric acid. The
asymmetric unit of the crystal contains two paracetamol molecules hydrogen-bonded to the citric acid;
one of these acts as a phenolic-OH hydrogen bond donor to the carbonyl of a carboxylic acid arm of
citric acid. In contrast, the other phenolic-OH acts as a hydrogen bond acceptor from the quaternary
C–OH of citric acid.1. Introduction
Pharmaceutical cocrystals are being investigated extensively as
they offer a variety of solutions to problems encountered in the
use of solid active pharmaceutical ingredients.1 The cocrystal
requires some partner molecule called the cocrystal former that
does not hamper the pharmaceutical activity of the API but
improves its physical, chemical or biological properties, and is
safe to use for human consumption.2 Cocrystallizing two or more
different molecules requires understanding of complementary
intermolecular interactions which can preferentially result in
heteromeric interactions over their homomeric counterparts.3,4
The cocrystals are a homogeneous phase of stoichiometric
composition and not a mixture of pure component crystalline
phases. Hydrogen bonds are the basis of molecular recognition
phenomena in pharmaceutical systems; moreover, they are key
elements in the design of molecular assemblies and super-
molecules in the solid states. In the crystalline state, hydrogen
bonds are accountable for the creation of families of molecular
networks with the same molecular components or with different
molecular components (multiple component crystals or cocrys-
tals).5–15 The cocrystals are stabilized through a variety of
different intermolecular interactions including hydrogen bonds,
aromatic p-stacking, and van der Waals forces, and unlike salt
formation, no proton transfer occurs between the API and theRaman Spectroscopy Group, University Analytical Centre, Division of
Chemical and Forensic Sciences, University of Bradford, West Yorkshire,
BD7 1DP, UK. E-mail: m.elbagermi@yahoo.co.uk
† CCDC reference number 803736. For crystallographic data in CIF or
other electronic format see DOI: 10.1039/c0ce00461h
This journal is ª The Royal Society of Chemistry 2011guest molecule.16 Slow evaporation and grinding are the most
commonly used techniques for producing cocrystals.17 The citric
acid molecule has two distinct hydrogen-bonding functions,
namely the hydroxyl and acid groups. In addition, the absence of
any aromatic functions offers the opportunity to probe directly
the aromatic functions of aromatic amide in the cocrystal: par-
acetamol.
Raman spectroscopy probes the effect of crystal structure on
bond vibrational energies and is potentially able to selectively
distinguish between the polymorphs of a given API. Further-
more, the measurements are noninvasive, nondestructive, and
rapid (data acquisition within seconds rather than minutes),
which make Raman spectroscopy ideal for automated high-
throughput analytical systems. Since Raman spectroscopy and
XRD are complementary techniques at the molecular level, in
combination they can provide an increased understanding of
solid-state phenomena. Karki et al. have reported an anhydrous
cocrystal of citric acid–caffeine and hydrated cocrystal of citric
acid–theophylline.18 Also, Myz et al. have studied a 1 : 1 citric
acid–meloxicam cocrystal.19 A number of paracetamol cocrystals
have been reported to date;20–22 Lemmerer et al. have studied
cocrystal of citric acid and nicotinamide formation of four
hydrogen bonding heterosynthons in one cocrystal;23 Schantz
et al. have studied citric acid anhydrous and paracetamol,
prepared as crystalline physical mixtures using solid-state
NMR,24 but a systematic synthesis and vibrational spectroscopy
characterization of the citric acid–paracetamol (CIT–Pa) coc-
rystal have not to our knowledge been studied hitherto.
The goals of this work were to: (1) describe the novel structural
studies of new cocrystals, (2) determine the vibrational modesCrystEngComm, 2011, 13, 1877–1884 | 1877
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View Article Onlinethat were most affected by formation and assembly of the
supramolecular synthons, and (3) determine the magnitude of
perturbation of the vibrational frequencies of the involved
modes. These goals necessitated the assignment of most of the
observed spectral features in the vibrational bands of the citric
acid and reactant, and tracking the energies of these bands in
a stoichiometric mixture. The spectroscopic results were sup-
ported by single-crystal X-ray diffraction, X-ray powder
diffraction and differential scanning calorimetry studies of the
same materials (Fig. 1).2. Experimental section
2.1. Materials
Citric acid (CIT) and paracetamol [monoclinic type 1 (PA)] were
purchased from Sigma Aldrich at >98%. These materials were
used as received. The solvent (ethanol) was HPLC grade and
obtained from Reidel de Haen or Fisher scientific.
Cocrystal formation was identified initially using Raman
spectroscopy and the difference in melting points between the
pure components and the product; the co-crystalline structures
were confirmed by X-ray powder diffraction and single crystal
X-ray diffraction.2.2. Cocrystallization via slow evaporation
Anhydrous citric acid (100 mg, 0.520 mmol) was mixed with
paracetamol (78.68 mg, 0.520 mmol) in stoichiometric ratio
(1 : 1) and was dissolved in 10 ml ethanol with slight warming
until dissolution was complete. The solution was then allowed to
slowly evaporate at room temperature (22–23 C). Then the solid
phase was harvested by vacuum filtration and dried at room
temperature under reduced pressure (25 mmHg) on Whatman
50 filter paper (Maidstone, England) for 30 minutes to remove
loosely bound solvent. The solid phases were confirmed to be
CIT:Pa cocrystal by X-ray powder diffraction, Raman spec-
troscopy, and differential scanning calorimetry.2.3. Raman spectroscopy
Raman spectra of the co-crystal samples and those of the single
components were obtained using a Via Raman microscope
(Renishaw plc.) with 785 nm stabilized diode laser excitation.
The laser power at the sample was approximately 25 mW. A 50
objective lens was used giving a laser spot diameter (footprint) of
about 2 mm at the sample. Spectra were obtained for a 10 s
exposure of the CCD detector in the wavenumber region 3600–
50 cm1 using the extended scanning mode of the instrument.Fig. 1 Molecular structure of (a) paracetamol and (b) citric acid.
1878 | CrystEngComm, 2011, 13, 1877–18842.4. Powder X-ray diffraction
Powder diffraction patterns of solid phases were recorded with
Bruker D8 diffractometer in Bragg–Brentano q–q geometry with
Cu Ka1,2 radiation (1.5418A) using a secondary curved graphite
monochromator. The X-ray tube was operated at 40 kV, 30 mA.
Samples were scanned in a vertical Bragg–Brentano (q/2q)
geometry (reflection mode) from 5 to 40 (2q) using a 0.005 step
width and a 1.5 s count time at each step. The receiving slit was 1
and the scatter slit 0.2. The solid phase was analyzed by X-ray
powder diffraction and results were compared to the diffraction
patterns of each pure phase.2.5. Differential scanning calorimetry (DSC)
The thermal behavior of the solid phases was studied using DSC;
the DSC profiles were generated in the range of 50 to 160 C
using a TA Q2000 DSC instrument with an RGS90 cooling unit.
Temperature calibration was performed using an indium metal
standard supplied with the instrument at the appropriate heating
rate of 10 C min1. Accurately weighed samples (1–2 mg) were
placed in Tzero aluminium pans using a similar empty pan as
reference. The data were collected in triplicate for each sample
and were analyzed using a TA Instruments Universal Analysis
2000 version 4.3A software.2.6. Single-crystal X-ray diffraction
Single crystal data were collected on a Bruker Apex II CCD
diffractometer with Mo Ka radiation (0.71073 A). The structure
was solved by direct methods with SHELXS-97 and refined by
a full-matrix least squares analysis on F2 with anisotropic
displacement parameters for non-H atoms in SHELXL-97.3. Characterization of the cocrystals
3.1. X-Ray powder diffraction (PXRD)
PXRD was used to identify crystalline phases and to qualita-
tively examine changes in crystallinity. The PXRD diffracto-
grams of the citric acid, paracetamol and of the products from
cocrystallization via slow evaporation from ethanol areFig. 2 Powder X-ray diffraction pattern of the CIT–Pa system (a) citric
acid, (b) paracetamol and (c) the cocrystal.
This journal is ª The Royal Society of Chemistry 2011
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View Article Onlinecompared in Fig. 2 and 3. The formation to the cocrystalline
phase is indicated by the diffraction peaks at positions 2q ¼ 7.5,
17.5 and 22.7, furthermore, some characteristic diffraction
peaks of the raw material have disappeared in the PXRD dif-
fractograms of the product via slow evaporation. Low intensity
broad peaks around 13.7, 14, 18.1 and 26.5, corresponding to
CIT and Pa, suggest the presence of unreacted crystalline mate-
rial. In addition, the XRD patterns confirm the formation of
a new complex phase.Fig. 4 DSC curve of the citric acid, paracetamol and cocrystal product.3.2. Differential scanning calorimetry (DSC)
The DSC of the cocrystallization product from slow evaporation
is presented in Fig. 4. The presence of unreacted component
would cause a decrease in the melting point. The DSC traces were
observed and the results are presented in Fig. 4. The results show
a single endothermic event at 154.5 C for pure citric acid and
pure paracetamol has an endothermic event at 170.5 C.
It is interesting that the cocrystal product also shows two
endotherms at 72.05 and 94.10 C, separated by a broad exo-
therm. This can be interpreted as a transition between enantio-
tropic polymorphic forms of the cocrystal. While such behaviour
is relatively uncommon, further study of this system was beyond
the scope of this project.Fig. 5 Raman spectra in the 3150–2850 cm1 region of (A) citric acid,
(B) paracetamol and (C) CIT–Pa cocrystal prepared from solution.3.3. Raman spectroscopic characterisation
Since cocrystal formation is the result of interactions between
different molecular components that also exist in the single-
component crystalline states, vibrational spectroscopy is an
excellent technique to characterize and study cocrystallization.
Differences in hydrogen bond interactions of the CIT–Pa coc-
rystals lead to significant changes in the Raman spectra as shown
in Fig. 5 and 6 and the vibrational wavenumbers and assignments
are listed in Table 1. Raman spectroscopic data were utilized
primarily to evaluate whether the complex is a simple physical
mixture or component of molecular ions. Anhydrous citric acid,
H3C6H5O7, is a tribasic acid with an OH group attached to the
middle carbon atom, whereas paracetamol contains a benzene
ring core, substituted by one hydroxyl group and the nitrogen
atom of an acetamide group in the para-position. There are two
activating groups that make the benzene ring highly reactiveFig. 3 Powder X-ray diffraction pattern of the CIT–Pa system (a) citric
acid, (b) paracetamol and (c) the cocrystal.
This journal is ª The Royal Society of Chemistry 2011toward electrophilic aromatic substitution. Paracetamol has
three crystalline polymorphs;25,26 monoclinic type 1 is the ther-
modynamically stable polymorph which has characteristic peaks
at 1325 and 1234 cm127 attributed to the amide III band (C–N
stretch/C–N–aromatic stretch/C–N–H bend) and nC–O,
sipHCC, nCC, sCCC, respectively.
The Raman spectrum of pure CIT (Fig. 5) starting material
shows peaks at 3001, 2964, 2956 and 2949 cm1. Through coc-
rystal formation of citric acid with paracetamol the bands at 3001
and 2964 were shifted to 2998 and 2978 cm1, respectively,
while the peaks at 2956 and 2949 cm1 appear as a broad band at
2953 cm1.Fig. 6 Raman spectra in the 1750–1350 cm1 region of (a) citric acid, (b)
paracetamol and (c) CIT–Pa cocrystal prepared from solution.
CrystEngComm, 2011, 13, 1877–1884 | 1879
Table 1 Assignments of major bands of Raman spectra of citric acid paracetamol and their cocrystal productsa
Citric acid solid (CIT) CIT : Pa Paracetamol (Pa) Assignment2931
2993w 2998vw —
2979w * —
2956w 2953w —
2949w —
— * 2931w Asymmetric CH3 stretch
1734s 1718vw — n(COOH)
— — —
1691vs 1668 sh — (C]O stretch)
— 1654 broad 1644vs Amide I band(C]O stretch)
1630 m broad —
— 1614m 1618vs nCC, sCCC, s
ip
HNC
— 1609vs nCC, s
ip
HNC, s
ip
HCC
— 1547 broad 1555s sipHNC, nCC, nasCNC, sipHCC
— 1508 broad 1514w sipHCC, sCCC, nCC
— 1505w Aryl C–H, C–H symmetric bends
1466 m broad 1453 broad CH2 sciss
1445w sasCH3
1430 m broad — C–OH def.
1387s — — CH2 scissors
— 1375 broad 1367s ssCH3
1346w * — O–CO bending of COOH
— 1321s 1325vvs Amide III band (C–N stretch/C–N–
ph stretch/C–N–H bend)
1276 broad 1278m n(C–N); d(N–H) amide III
— 1246w 1256m nC–O, sipHCC, nCC, sCCC
— 1235 broad 1234s nCC, sipHOC, sipHCC, nCNC
1217m 1222m — —
1205m 1203w — C–C stretching
— 1191w — —
— 1175 — —
— 1168m 1165m sipHCC, nCC
1165w — —
1141m 1129w —
* 1121vvw nCC, sHOC
— 1103vvw 1106w sipHCC, nCC, sipHOC
1080m * — C–O stretch
1050m 1061vw broad — C–O stretch
— * 1014w sCH3, sCCC
— 968 966m H–C–C bend
960
939s * — C–C symmetric stretch
900m * — C–C bends and OH out-of-plane
bending
— 860m 860 vs Aromatic ring bend
— 834w 836 m Out-of-plane C–H bend (aryl-1,4-
disubsituted)
877w * —
— 788s 796s Aromatic ring stretches
— — —
780s — —
— 776 —
— 699w broad 710m Aromatic ring bend
682m 697vw broad — C]O stretching
— * 685wsh Out-of-plane wagging of NH
(amide group)
— 648w broad 650m Aromatic ring bend
636w — — —
— 623vvw 626w Amide IV band (H–N–C
deformation)
593m 597vw broad 606w sC–CH3
550m * — —
539sh * — —
— 497w broad 503m Skeleton vibration
499w — —
— * 463m Aromatic ring bend
417m 412vw — —
— * 412w s in-plane
— 389s broad 388s C–N bend
345m 355vw — —
301m — — —
— 324 328m —
1880 | CrystEngComm, 2011, 13, 1877–1884 This journal is ª The Royal Society of Chemistry 2011
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View Article Online
Fig. 7 Raman spectra in the 1400–950 cm1 region of (a) citric acid, (b) paracetamol and (c) CIT–Pa cocrystal prepared from solution.
Table 1 (Contd. )
Citric acid solid (CIT) CIT : Pa Paracetamol (Pa) Assignment2931
258m broad * — —
212 211w broad 215m —
a Where * disappeared during the cocrystal.
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View Article OnlineParacetamol has peaks at 3110, 3058 and 2935 cm1 and in
those in the complex at 3110 and 3058 cm1 appeared as very
weak and broad at the same position. At the same time as the
peak at 2935 cm1 was shifted to 2953 cm1 to appear as a broad
peak in the same region as the individual peaks at 2956 and
2949 cm1 of the citric acid alone.
Pure citric acid has bands at 1734 and 1691 cm1, corre-
sponding to the n(COOH) and (C]O stretch), respectively.
During cocrystallization these bands in the cocrystal were shifted
to 1718 cm1 as a weak broad band and 1668 cm1 as a weak
shoulder, respectively. The decrease in the n(COOH) and C]O
stretching wavenumbers of citric acid from 1734 to 1718 cm1Fig. 8 Raman spectra in the 1000–550 cm1 region of (a) citric acid, (
This journal is ª The Royal Society of Chemistry 2011and from 1691 to 1668 cm1 indicates that the carboxyl group is
participating in strong hydrogen bonding. Furthermore the
broad peak at 1630 cm1 disappears in the cocrystal as shown in
Fig. 6.
The peaks in the spectrum of paracetamol at 1644, 1618, 1609
and 1555 cm1 are attributed to the amide I band (C]O stretch),
nCC, sCCC, sipHNC, nCC, sipHNC, sipHCC and sipHNC,
nCC, nasCNC, sipHCC, respectively; during the cocrystal
formation these peaks were shifted to 1654, 1611, 1611, and
a weak broad band at 1547 cm1, respectively. As shown in Fig. 6
and Table 1, during the formation of a CIT–Pa cocrystal the
(C]O), (COOH) and (NH) bands of citric acid and paracetamolb) paracetamol and (c) CIT–Pa cocrystal prepared from solution.
CrystEngComm, 2011, 13, 1877–1884 | 1881
Fig. 9 Raman spectra in the 550–100 cm1 region of (a) citric acid, (b) paracetamol and (c) CIT–Pa cocrystal prepared from solution.
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View Article Onlineare shifted to higher or lower wavenumbers by 8 to 23 cm1
accompanied by corresponding decreases in the band intensities;
which suggest that the molecular complex of citric acid and
paracetamol is a cocrystal and not simply a physical mixture of
these components. In addition, the doublet at 1514 and
1505 cm1 in the spectrum of pure paracetamol now appears as
a single band at 1508 cm1 in the cocrystal spectrum.
The CH2 scissors band at 1466 cm
1 in the spectrum of citric
acid and (sasCH3) band at 1445 cm
1 in the spectrum of para-
cetamol are shifted to appear as a single broad band at
1453 cm1. In the citric acid spectrum the peaks at 1430 (C–OH
def.) and 1387 cm1 disappeared during cocrystal formation,Table 2 Crystal data and structure refinement for [para]2[cit]
Identification code me_para_citric_0m
Empirical formula C22H26N2O11
Formula weight 494.45
Temperature 296(2) K
Wavelength 0.71073 A
Crystal system Monoclinic
Space group C2/c
Unit cell dimensions a ¼ 24.2864(10) A, a ¼ 90
b ¼ 11.3217(5) A, b ¼ 107.988(2)
c ¼ 16.9668(7) A, g ¼ 90
Volume 4437.2(3) A3
Z 8
Density (calculated) 1.480 mg m3
Absorption coefficient 0.120 mm1
F(000) 2080
Crystal size 0.35  0.27  0.23 mm3
q Range for data collection 2.00 to 27.49
Index ranges 27 # h # 24, 14 # k # 12, 12
# l # 22
Reflections collected 10 850
Independent reflections 4056 [R(int) ¼ 0.0350]
Completeness to q ¼ 27.49 79.6%
Absorption correction None
Max. and min. transmission 0.9731 and 0.9587
Refinement method Full-matrix least-squares on F2
Data/restraints/parameters 4056/0/349
Goodness-of-fit on F2 1.011
Final R indices [I > 2s(I)] R1 ¼ 0.0474, wR2 ¼ 0.0811
R indices (all data) R1 ¼ 0.0839, wR2 ¼ 0.0920
Largest diff. peak and hole 0.221 and 0.249 e A3
1882 | CrystEngComm, 2011, 13, 1877–1884while the peak at 1367 cm1 in the pure paracetamol was shifted
to a higher wavenumber and centred at 1375 cm1.
The spectrum of citric acid showed a peak corresponding to
the O–CO bending of the carboxylic group at 1346 cm1 and this
band also appears in the cocrystal spectrum. In the spectrum of
paracetamol, the bands observed at 1256, 1234 and 1269 cm1
were assigned to the (nC–O, sipHCC, nCC, sCCC), (nCC,
sipHOC, sipHCC, nCNC) and sipHCC, nCC, respectively.
These bands in the cocrystal were shifted to 1246 cm1 as a weak
broad band, 1233 cm1 as a broad band with decreased intensity
and 1268 cm1 as a weak shoulder, respectively. Moreover, two
new medium bands are now observed at 1175 and 776 cm1,
which do not occur in either the citric acid or the paracetamol
(Fig. 7 and 8). The Raman spectrum of citric acid starting
material has bands at 1050, 939 and 900 cm1 assigned to C–O
stretching, C–C symmetric stretching and C–C bending and OH
out-of-plane bending, respectively. During the cocrystal forma-
tion, the band at 1050 cm1 was shifted to 1061 cm1 and now
appears as a broad weak band, while the peaks at 939 and
900 cm1 disappear all together from the spectrum.
On the other hand, the Raman spectrum of paracetamol has
a single peak at 966 cm1 attributed to H–C–C bending; through
cocrystal formation this peak becomes a doublet with intensity
increasing as shown in Fig. 8. The peak at 682 cm1Table 3 Hydrogen bond dimensions (d/A;:/) in the 2 : 1 co-crystal of
citric acid and paracetamol
D–H d(D–H) d(H/A) :(D–H/A) d(D/A) A
O3–H3O 0.831 1.938 171.57 2.763 O1A
O5–H5O 0.882 1.809 169.65 2.681 O3a
O6–H6O 0.996 1.622 176.83 2.617 O7b
O8–H8O 0.942 1.677 176.64 2.618 O9b
N1A–H1NA 0.880 2.267 172.59 3.141 O1Bc
O1A–H1OA 0.832 1.839 166.57 2.656 O2Bd
N1B–H1NB 0.854 2.150 145.79 2.896 O2Ae
O1B–H1OB 0.851 2.156 176.29 3.006 O4
a [x + ½, y + ½, z + ½]. b [x + ½, y + ½, z + 1]. c [x, y, z  ½].
d [x, y + 1, z  ½]. e [x, y, z + 1].
This journal is ª The Royal Society of Chemistry 2011
Fig. 10 The chain of citric acid molecules formed from centrosymmetric
acid–acid dimer motifs propagating parallel to the c-axis of the unit cell.
Fig. 12 Amide NH/O hydrogen bonding linking pairs of paracetamol
molecules in the crystal.
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View Article Onlinecorresponding to C]O stretching was observed at 692 cm1 as
a weak broad band in the cocrystal spectrum.
Furthermore, the peaks at 636 and 550 cm1 disappear in the
cocrystal (Fig. 9). The peaks at 626 cm1 (H–N–C deformation)
and 463 cm1 (aromatic ring bend), cocrystal formation are now
centred at 648, 623 and 389 cm1 as broad weak peaks. Hydrogen
bonding is a significant intermolecular interaction, which is
responsible for the different crystal packing.28 Raman spectros-
copy results suggest that the citric acid and paracetamol are now
in the cocrystal form and they are not a simple physical mixture.3.4. Single-crystal X-ray diffraction
The single crystal X-ray structure confirmed that a cocrystal had
been formed and showed the structural centrepiece of the crystal
system to be 2 : 1 with respect to paracetamol and citric acid
(Tables 2 and 3). The asymmetric unit of the crystal contains two
paracetamol molecules hydrogen-bonded to the citric acid; one
of these acts as a phenolic-OH hydrogen bond donor to the
carbonyl of a carboxylic acid arm of citric acid. In contrast,
the other phenolic-OH acts as a hydrogen bond acceptor from
the quaternary C–OH of citric acid.
The structural centrepiece in the crystal packing is the citrate
chain formed by centrosymmetric carboxylic acid dimmers. The
chain propagates parallel to the c-axis (Fig. 10).
Citric acid molecular chains cross-link through the formation
of COOH/OH hydrogen bonds to the COH of an adjacent
chain resulting in a sheet structure (Fig. 11). Pairs of paracetamol
molecules, hydrogen bonded through intermolecular amide/
amide bonds (Fig. 12) span every other citric acid molecule in the
chain, forming a phenolic OH to carbonyl H-bond at one end ofFig. 11 Cross-linking of citric acid chains
This journal is ª The Royal Society of Chemistry 2011the pair and citric OH/O of the phenolic OH at the other end of
the pair (Fig. 13). Curiously, one NH amide does not appear to
be involved in hydrogen bonding.
The paracetamol phenolic OH also cross-links the chain
structures. The phenol with H-bonding through the oxygen to
the citrate chain also acts as an H-bond donor to the amide
oxygen (O2B) of the adjacent chain. This relationship corre-
sponds with the c-glide plane of the crystal symmetry (Fig. 14).4. Conclusion
A pharmaceutical cocrystal of citric acid with paracetamol was
designed employing crystal engineering strategies. Citric acid–
paracetamol cocrystal was prepared via a slow evaporation
method and formed 1 : 2 complexes. The single crystal structure
of citric acid–paracetamol cocrystal was determined. Also, DSC,
PXRD, and Raman data confirmed the formation and stability
of the citric acid–paracetamol cocrystal. Raman spectroscopy
was found to be a useful spectroscopic technique for character-
ization of these products. Formation of the cocrystal results in
changes in the carbonyl band region that is diagnostic for the
existence of the citric acid–paracetamol cocrystal.
The single crystal X-ray structure confirmed that a cocrystal
had been formed. The asymmetric unit of the crystal contains
two paracetamol molecules hydrogen-bonded to the citric acid;
one of these acts as a phenolic-OH hydrogen bond donor to the
carbonyl of a carboxylic acid arm of citric acid. In contrast, theviewed down the a-axis of the unit cell.
CrystEngComm, 2011, 13, 1877–1884 | 1883
Fig. 13 The attachment of pairs of paracetamol molecules to the citric acid molecular chain viewed down the b-axis of the unit cell.
Fig. 14 The crystal packing of the 2 : 1 cocrystal of paracetamol and citric acid showing the ‘crosslinking’ between chains of paracetamol and citric acid
units viewed down the a-axis of the unit cell.
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View Article Onlineother phenolic-OH acts as a hydrogen bond acceptor from the
quaternary C–OH of citric acid.
Citric acid molecular chains cross-link through the formation
of COOH/OH hydrogen bonds to the COH of an adjacent
chain resulting in a sheet structure. Pairs of paracetamol mole-
cules, hydrogen bonded through intermolecular amide/amide
bonds span every other citric acid molecule in the chain, forming
a phenolic OH to carbonyl H-bond at one end of the pair and
citric OH/O of the phenolic OH at the other end of the pair.
Curiously, one NH amide does not appear to be involved in
hydrogen bonding.
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